MannKind | MNKD - Pre Tax Profit

Stock Price
5.79
Daily Change
0.28 4.99%
Monthly
-1.11%
Yearly
2.75%
Q1 Forecast
5.60

MannKind reported $7.78M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Adma Biologics USD 47.52M 7.42M Sep/2025
Dynavax Technologies USD 28.42M 7.2M Sep/2025
Eli Lilly USD 7.23B 456M Sep/2025
Halozyme Therapeutics USD 218.96M 14.02M Sep/2025
Insmed USD -368.7M 48.26M Sep/2025
MacroGenics USD 16.82M 52.97M Sep/2025
MannKind USD 7.78M 6.84M Sep/2025
Merck USD 6.74B 22M Sep/2025
Novo Nordisk DKK 25.52B 8.29B Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Sanofi EUR -1.16B 5.5B Dec/2025
Xencor USD -6.03M 25.05M Sep/2025